Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 4/20 | 0.53 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.53 |
| ▸ | POLB | P06746 | 2/20 | 0.53 |
| ▸ | GAA | P10253 | 1/20 | 0.48 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.47 |
| ▸ | TP53 | P04637 | 1/20 | 0.46 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.46 |
| ▸ | RECQL | P46063 | 1/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.44 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.44 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.44 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.44 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.44 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.44 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.44 |
| ▸ | ADORA3 | P0DMS8 | 3/20 | 0.44 |
| ▸ | ADORA2A | P29274 | 3/20 | 0.44 |
| ▸ | ADORA1 | P30542 | 2/20 | 0.44 |
| ▸ | ADORA2B | P29275 | 1/20 | 0.44 |
| ▸ | SGMS1 | Q86VZ5 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1880366 | 0.91 | MEN1 (0.50) | MEN1KMT2APOLBGAAMAPK1 | |
| SCHEMBL17023223 | 0.84 | GAA (0.48) | MEN1KMT2APOLBGAAMAPK1 | |
| SCHEMBL1875570 | 0.82 | KMT2A (0.48) | MEN1KMT2APOLBGAAALDH1A1 | |
| SCHEMBL21225109 | 0.81 | KMT2A (0.47) | MEN1KMT2APOLBGAAALDH1A1 | |
| SCHEMBL21224988 | 0.81 | KMT2A (0.47) | MEN1KMT2APOLBGAAALDH1A1 | |
| SCHEMBL21225118 | 0.81 | KMT2A (0.47) | MEN1KMT2APOLBGAAALDH1A1 | |
| SCHEMBL1876493 | 0.75 | ADORA3 (0.45) | MEN1KMT2AALDH1A1ADORA3ADORA2A | |
| SCHEMBL1876938 | 0.75 | KMT2A (0.48) | MEN1KMT2AALDH1A1CYP1A2CYP3A4 | |
| SCHEMBL1876346 | 0.74 | KMT2A (0.47) | MEN1KMT2APOLBGAATP53 | |
| Potassium Ion SCHEMBL29446260 | 0.73 | KMT2A (0.46) | MEN1KMT2APOLBGAAALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210047279-A1 | SALT FORMS OF ORGANIC COMPOUND | KAINOS MEDICINE INC. (KR) | 2021-02-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210047279-A1 | SALT FORMS OF ORGANIC COMPOUND | SLC10A6, SLC10A1, SLCO4C1 | MEN1 1691/4885KMT2A 2753/4885POLB 2599/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.